Clinical Trial Update: EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders) [Phase 4]

View source ↗

Summary

EMERALD is a Phase 4 trial evaluating emergency medicine cardiovascular risk assessment for lipid disorders; the study has completed and results were posted on …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Lipid Disorder | Phase 4 | Status: COMPLETED | Results posted: 2024-03-20